NASDAQ: GLMD
Galmed Pharmaceuticals Ltd Stock Ownership - Who owns Galmed Pharmaceuticals?

Insider buying vs selling

Have Galmed Pharmaceuticals Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when GLMD insiders and whales buy or sell their stock.

GLMD Shareholders

What type of owners hold Galmed Pharmaceuticals Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Two Sigma Investments LP2.05%112,147$73.01kInstitution
Citadel Advisors LLC0.70%38,177$24.85kInstitution
Two Sigma Advisers LP0.57%31,491$20.50kInstitution
Two Sigma Securities LLC0.25%13,602$8.85kInstitution
Jane Street Group LLC0.22%12,135$7.90kInstitution
Xtx Topco Ltd0.20%11,048$7.19kInstitution
Ubs Group Ag0.03%1,814$1.18kInstitution
Bnp Paribas Financial Markets0.02%900$585.90Institution
Morgan Stanley0.01%298$194.00Institution
Tsfg LLC0.00%17$11.07Institution

1 of 2

GLMD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GLMD4.05%0.00%
MTVA0.11%99.89%Net Buying
GRI2.12%97.88%
OGEN0.54%99.46%Net Selling
DCOY0.67%99.33%Net BuyingNet Selling

Galmed Pharmaceuticals Stock Ownership FAQ

Who owns Galmed Pharmaceuticals?

Galmed Pharmaceuticals (NASDAQ: GLMD) is owned by 4.05% institutional shareholders, 0.00% Galmed Pharmaceuticals insiders, and 95.95% retail investors. Two Sigma Investments LP is the largest individual Galmed Pharmaceuticals shareholder, owning 112,147.00 shares representing 2.05% of the company. Two Sigma Investments LP's Galmed Pharmaceuticals shares are currently valued at $70.65k.

If you're new to stock investing, here's how to buy Galmed Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.